Increased Tissue Arachidonic Acid and Reduced Linoleic Acid in a Mouse Model of Cystic Fibrosis Are Reversed by Supplemental Glycerophospholipids Enriched in Docosahexaenoic Acid (original) (raw)

Increased tissue arachidonic acid and reduced linoleic acid in a mouse model of cystic fibrosis are reversed by supplemental glycerophospholipids enriched in …

teresinha leal

The Journal of …, 2009

View PDFchevron_right

Oral DHA supplementation in deltaF 508 homozygous cystic fibrosis patients

Saskia Vande Velde

Acta Gastro-enterologica Belgica, 2008

View PDFchevron_right

Low linoleic and high docosahexaenoic acids in a severe phenotype of transgenic cystic fibrosis mice

Mohamed ALi

Experimental biology and medicine (Maywood, N.J.), 2018

View PDFchevron_right

Not Just any Fat for Cystic Fibrosis? Docosahexaenoic Acid in Cystic Fibrosis

Jean Pierre Van Biervliet, Eddy Robberecht, Stephanie Van Biervliet

Current Pediatric Reviews, 2006

View PDFchevron_right

Docosahexaenoic acid trials in cystic fibrosis: A review of the rationale behind the clinical trials

Stephanie Van Biervliet

Journal of Cystic Fibrosis, 2005

View PDFchevron_right

Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial

Oscar Asensio de la Cruz

Journal of Clinical Medicine

View PDFchevron_right

Linoleic acid supplementation results in increased arachidonic acid and eicosanoid production in CF airway cells and in cftr-/- transgenic mice

Abdul Malik Bhutta

AJP: Lung Cellular and Molecular Physiology, 2010

View PDFchevron_right

The absorption and effect of dietary supplementation with omega-3 fatty acids on serum leukotriene B4, in patients with cystic fibrosis

Maurice Bennink

Pediatric Pulmonology, 1994

View PDFchevron_right

Increasing Dietary α-Linolenic Acid Enhances Tissue Levels of Long-Chain n-3 PUFA when Linoleic Acid Intake Is Low in Hamsters

Valerie Casey

Annals of Nutrition and Metabolism, 2010

View PDFchevron_right

Upregulated liver conversion of -linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet

Miki Igarashi

The Journal of Lipid Research, 2006

View PDFchevron_right

Persistence of Essential Fatty Acid Deficiency in Cystic Fibrosis Despite Nutritional Therapy

Jose Luis Prieto

Pediatric Research, 2009

View PDFchevron_right

LONG-TERM DOCOSAHEXAENOIC ACID THERAPY IN A CONGENIC MURINE MODEL OF CYSTIC FIBROSIS

Catherine Luk, Peter Durie

2000

View PDFchevron_right

A comprehensive evaluation of omega-3 fatty acid supplementation in cystic fibrosis patients using lipidomics

ADELAIDA FERREIRO

The Journal of Nutritional Biochemistry, 2019

View PDFchevron_right

Comparative effects of high oleic acid vs high mixed saturated fatty acid obesogenic diets upon PUFA metabolism in mice

Joseph Idso

Prostaglandins, leukotrienes, and essential fatty acids, 2017

View PDFchevron_right

Fatty acids platelets and oxidative markers following intravenous n-3 fatty acids administration in cystic fibrosis: An open pilot observational study

Eric Fontaine

Journal of Cystic Fibrosis, 2007

View PDFchevron_right

Effect of dietary docosahexaenoic acid on desaturation and uptake in vivo of isotope-labeled oleic, linoleic, and linolenic acids by male subjects

Edward Emken

Lipids, 1999

View PDFchevron_right

A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr-/- mice

Eliza Parker

Proceedings of the National Academy of Sciences, 1999

View PDFchevron_right

Increased Δ5- and Δ6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis

michael njoroge

Biochimica Et Biophysica Acta-molecular and Cell Biology of Lipids, 2011

View PDFchevron_right

Fatty acid composition of serum phospholipids in cystic fibrosis (CF) patients with or without CF related liver disease

Stephanie Van Biervliet

Clinical Chemistry and Laboratory Medicine, 2010

View PDFchevron_right

Abnormal Fatty-Acid Composition of Plasma-Lipids in Cystic Fibrosis

Van Hubbard

The Lancet, 1977

View PDFchevron_right

What is the association of essential fatty acid status with cystic fibrosis?

Van Hubbard

European Journal of Pediatrics, 1983

View PDFchevron_right

Evidence of increased flux to n-6 docosapentaenoic acid in phospholipids of pancreas from cftr −/− knockout mice

Mario ollero

Metabolism-clinical and Experimental, 2006

View PDFchevron_right

The effect of varying ratios of docosahexaenoic acid and arachidonic acid in the prevention and reversal of biochemical essential fatty acid deficiency in a murine model

Bruce Bistrian

Metabolism: clinical and experimental, 2013

View PDFchevron_right

Fatty Acid Metabolism in Cystic Fibrosis

Birgitta Strandvik

The New England Journal of Medicine, 2004

View PDFchevron_right

Impact of the -3 to -6 Polyunsaturated Fatty Acid Ratio on Cytokine Release in Human Alveolar Cells

Giuliana Muzio

Journal of Parenteral and Enteral Nutrition, 2011

View PDFchevron_right

Vegetable oils rich in alpha linolenic acid allow a higher accretion of n-3 LCPUFA in the plasma, liver and adipose tissue of the rat

JULIO SANHUEZA

Grasas y Aceites, 2014

View PDFchevron_right

The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide

Juan De Sanctis

Cellular and Molecular Life Sciences, 2020

View PDFchevron_right

An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis

Pierre Wallemacq, Teresinha Leal

Clinical Biochemistry, 2007

View PDFchevron_right